Show simple item record

dc.contributor.authorWilkinson, S.
dc.contributor.authorGunosewoyo, Hendra
dc.contributor.authorBarron, M.
dc.contributor.authorBoucher, A.
dc.contributor.authorMcDonnell, M.
dc.contributor.authorTurner, P.
dc.contributor.authorMorrison, D.
dc.contributor.authorBennett, M.
dc.contributor.authorMcGregor, I.
dc.contributor.authorRendina, L.
dc.contributor.authorKassiou, M.
dc.date.accessioned2017-01-30T12:51:35Z
dc.date.available2017-01-30T12:51:35Z
dc.date.created2014-06-17T20:00:15Z
dc.date.issued2014
dc.identifier.citationWilkinson, S. and Gunosewoyo, H. and Barron, M. and Boucher, A. and McDonnell, M. and Turner, P. and Morrison, D. et al. 2014. The First CNS-Active Carborane: A Novel P2X7 Receptor Antagonist with Antidepressant Activity. ACS Chemical Neuroscience. 5 (5): pp. 335-339.
dc.identifier.urihttp://hdl.handle.net/20.500.11937/26070
dc.identifier.doi10.1021/cn500054n
dc.description.abstract

Relative to other polycyclic frameworks (1-3), a carborane cage (4 and Cs·5) exerts a significant biological effect as an inhibitor of the purinergic P2X7 receptor (P2X7R) which allows one to target depression in vivo and thus demonstrate, for the first time, that a carborane has the capacity to modify CNS activity

dc.publisherAmerican Chemical Society
dc.subjectpolycycle
dc.subjectblood-brain barrier
dc.subjectantidepressant
dc.subjectP2X7
dc.subjectCarborane
dc.titleThe First CNS-Active Carborane: A Novel P2X7 Receptor Antagonist with Antidepressant Activity
dc.typeJournal Article
dcterms.source.volume5
dcterms.source.startPage335
dcterms.source.endPage339
dcterms.source.issn1948-7193
dcterms.source.titleACS Chemical Neuroscience
curtin.departmentSchool of Pharmacy
curtin.accessStatusFulltext not available


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record